Kelso Technologies I (KEOSF) 5.7500 $KEOSF
Kelso Technologies Inc.: Grant of Option
Marketwire - Mon Jul 07, 12:32PM CDT
Kelso Technologies Inc. (the "Company" or "Kelso"
(TSX: KLS)(OTCQX: KEOSF) -
Kelso to Trade on Toronto Stock Exchange May 22, 2014
Marketwire - Tue May 20, 12:19PM CDT
Kelso Technologies Inc. (the "Company" or "Kelso" (TSX VENTURE: KLS)(OTCQX: KEOSF) -The Company reports that it has been approved for listing and will commence trading on the Toronto Stock Exchange, Canada's senior stock exchange at the open of markets on Thursday, May 22, 2014. The Company's shares will be delisted from the TSX Venture Exchange upon commencement of trading on TSX.
Kelso Technologies Inc.: Financial Results for the Three Months Ended March 31, 2014
Marketwire - Wed May 14, 8:04AM CDT
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) -
Kelso Receives Conditional Listing Approval from TSX Exchange
Marketwire - Thu May 08, 11:10AM CDT
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) -
Kelso Declares Annual Dividend
Marketwire - Wed Apr 02, 8:05AM CDT
Kelso Technologies Inc. (The "Company" or "Kelso" (TSX VENTURE: KLS)(OTCQX: KEOSF) -
Kelso Technologies Inc.: Financial Results for the Year Ended December 31, 2013
Marketwire - Mon Mar 31, 8:05AM CDT
Kelso Technologies Inc. (the "Company" or "Kelso" (TSX VENTURE: KLS)(OTCQX: KEOSF) - The Company reports that it has released its audited financial statements and Management Discussion and Analysis for the year ended December 31, 2013.
Kelso Technologies Inc.: Business Development Alliance With SafeRack
Marketwire - Thu Mar 20, 8:03AM CDT
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) - The Company reports that it has formed a strategic business and engineering alliance with SafeRack Loading Rack Technologies ("SafeRack". The goal is to incorporate Kelso's one-bolt Kelso Klincher(R) Manway ("KKM" technology as an integral part of a new generation of high-capacity crude oil loading terminal systems designed and provided by SafeRack. SafeRack is the leading expert in crude oil and liquid natural gas loading terminal engineering, procurement and construction services for the railroad and trucking industry.
Kelso Technologies Inc.: New Patent-Dual Rating Pressure Relief Valve
Marketwire - Thu Feb 20, 8:04AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) - The Company reports that it has filed a patent application for a new externally mounted dual rating pressure relief valve ("DPRV" design for use on new rail tank cars and retrofits of existing rail tank cars.
Kelso Ranked as 2014 TSX Venture 50(R) Company
Marketwire - Wed Feb 12, 11:08AM CST
Kelso Technologies Inc. (the "Company" or "Kelso" (TSX VENTURE: KLS)(OTCQX: KEOSF) -
Advanced Proteome Therapeutics Corp. (APC) Provides Update on Ongoing Activities
Marketwire - Thu Dec 19, 1:07PM CST
Advanced Proteome Therapeutics Corporation ("APC" or the "Company" (TSX VENTURE: APC) is pleased to announce that through calendar year 2013 the Company has been applying its enabling Foundation Trinity(TM) Technology to proteins targeted for the treatment of cancers. Advanced, targeted therapies are intended to attack primarily cancer cells and are expected to dominate the anti-cancer therapeutics market in the near future. APC's technology will enable not only therapy targeted for tumor cells, but also the delivery of combination therapy in a single, pure therapeutic agent. To achieve this, it has been the Company's intention to utilize a unique protein, not only as a delivery system to tumor cells, but also as a scaffold upon which to attach each anti-cancer entity to its own specific site on the protein surface - both key to efficient manufacturing and product development. What is more, the protein itself appears to possess immunotherapeutic properties. Immunotherapy is perhaps the most powerful current approach to cancer, and one of great commercial interest to the pharmaceutical industry. This vision, the unique nature of the protein, and the ability to apply its proprietary enabling chemical technology to modification of the protein, differentiate APC from the competition.
C5 Insight Lauded With Top Awards and Honors in 2013
GlobeNewswire - Wed Dec 18, 2:09PM CST
C5 Insight, a technology consulting firm that specializes in customizing and implementing multiple customer relationship management (CRM) and enterprise collaboration solutions, reports another year of award-winning growth and success.
Kelso Technologies Inc.: Grant of Option
Marketwire - Mon Jul 07, 12:32PM CDT
Kelso Technologies Inc. (the "Company" or "Kelso"
(TSX: KLS)(OTCQX: KEOSF) - Kelso to Trade on Toronto Stock Exchange May 22, 2014
Marketwire - Tue May 20, 12:19PM CDT
Kelso Technologies Inc. (the "Company" or "Kelso"
(TSX VENTURE: KLS)(OTCQX: KEOSF) -The Company reports that it has been approved for listing and will commence trading on the Toronto Stock Exchange, Canada's senior stock exchange at the open of markets on Thursday, May 22, 2014. The Company's shares will be delisted from the TSX Venture Exchange upon commencement of trading on TSX. Kelso Technologies Inc.: Financial Results for the Three Months Ended March 31, 2014
Marketwire - Wed May 14, 8:04AM CDT
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) -
Kelso Receives Conditional Listing Approval from TSX Exchange
Marketwire - Thu May 08, 11:10AM CDT
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) -
Kelso Declares Annual Dividend
Marketwire - Wed Apr 02, 8:05AM CDT
Kelso Technologies Inc. (The "Company" or "Kelso"
(TSX VENTURE: KLS)(OTCQX: KEOSF) - Kelso Technologies Inc.: Financial Results for the Year Ended December 31, 2013
Marketwire - Mon Mar 31, 8:05AM CDT
Kelso Technologies Inc. (the "Company" or "Kelso"
(TSX VENTURE: KLS)(OTCQX: KEOSF) - The Company reports that it has released its audited financial statements and Management Discussion and Analysis for the year ended December 31, 2013. Kelso Technologies Inc.: Business Development Alliance With SafeRack
Marketwire - Thu Mar 20, 8:03AM CDT
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) - The Company reports that it has formed a strategic business and engineering alliance with SafeRack Loading Rack Technologies ("SafeRack"
. The goal is to incorporate Kelso's one-bolt Kelso Klincher(R) Manway ("KKM" technology as an integral part of a new generation of high-capacity crude oil loading terminal systems designed and provided by SafeRack. SafeRack is the leading expert in crude oil and liquid natural gas loading terminal engineering, procurement and construction services for the railroad and trucking industry. Kelso Technologies Inc.: New Patent-Dual Rating Pressure Relief Valve
Marketwire - Thu Feb 20, 8:04AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) - The Company reports that it has filed a patent application for a new externally mounted dual rating pressure relief valve ("DPRV"
design for use on new rail tank cars and retrofits of existing rail tank cars. Kelso Ranked as 2014 TSX Venture 50(R) Company
Marketwire - Wed Feb 12, 11:08AM CST
Kelso Technologies Inc. (the "Company" or "Kelso"
(TSX VENTURE: KLS)(OTCQX: KEOSF) - Advanced Proteome Therapeutics Corp. (APC) Provides Update on Ongoing Activities
Marketwire - Thu Dec 19, 1:07PM CST
Advanced Proteome Therapeutics Corporation ("APC" or the "Company"
(TSX VENTURE: APC) is pleased to announce that through calendar year 2013 the Company has been applying its enabling Foundation Trinity(TM) Technology to proteins targeted for the treatment of cancers. Advanced, targeted therapies are intended to attack primarily cancer cells and are expected to dominate the anti-cancer therapeutics market in the near future. APC's technology will enable not only therapy targeted for tumor cells, but also the delivery of combination therapy in a single, pure therapeutic agent. To achieve this, it has been the Company's intention to utilize a unique protein, not only as a delivery system to tumor cells, but also as a scaffold upon which to attach each anti-cancer entity to its own specific site on the protein surface - both key to efficient manufacturing and product development. What is more, the protein itself appears to possess immunotherapeutic properties. Immunotherapy is perhaps the most powerful current approach to cancer, and one of great commercial interest to the pharmaceutical industry. This vision, the unique nature of the protein, and the ability to apply its proprietary enabling chemical technology to modification of the protein, differentiate APC from the competition. C5 Insight Lauded With Top Awards and Honors in 2013
GlobeNewswire - Wed Dec 18, 2:09PM CST
C5 Insight, a technology consulting firm that specializes in customizing and implementing multiple customer relationship management (CRM) and enterprise collaboration solutions, reports another year of award-winning growth and success.
